Literature DB >> 28433105

Symptomatic treatment of neurologic symptoms in Wilson disease.

Tomasz Litwin1, Petr Dušek2, Anna Członkowska3.   

Abstract

Wilson disease (WD) is a potentially treatable neurodegenerative disorder. In the majority of cases, treatment with drugs that induce a negative copper balance (usually chelators or zinc salts) leads to improvements in liver function and neurologic signs. However, some patients show severe neurologic symptoms at diagnosis, such as tremor, dystonia, parkinsonism, and chorea. In this patient group, some neurologic deficits may persist despite adequate treatment, and further neurologic deterioration may be observed after treatment initiation. Such patients may require additional treatment to alleviate neurologic symptoms. Apart from general recommendations for WD anticopper treatment, there are currently no guidelines for managing neurologic symptoms in WD. The aim of this chapter is to summarize possible treatments of neurologic symptoms in WD based on the presently available medical literature.
© 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Wilson disease; botulinum toxin; deep-brain stimulation; dopamine; dystonia; parkinsonism; tremor

Mesh:

Substances:

Year:  2017        PMID: 28433105     DOI: 10.1016/B978-0-444-63625-6.00018-5

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  13 in total

Review 1.  Wilson disease-treatment perspectives.

Authors:  Tomasz Litwin; Karolina Dzieżyc; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 2.  Clinical management of Wilson disease.

Authors:  Peter Hedera
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  Wilson disease.

Authors:  Anna Członkowska; Tomasz Litwin; Petr Dusek; Peter Ferenci; Svetlana Lutsenko; Valentina Medici; Janusz K Rybakowski; Karl Heinz Weiss; Michael L Schilsky
Journal:  Nat Rev Dis Primers       Date:  2018-09-06       Impact factor: 52.329

5.  MR Imaging of the Brain in Neurologic Wilson Disease.

Authors:  X-E Yu; S Gao; R-M Yang; Y-Z Han
Journal:  AJNR Am J Neuroradiol       Date:  2019-01       Impact factor: 3.825

Review 6.  Sleep Disorders in Wilson's Disease.

Authors:  Valérie Cochen De Cock; France Woimant; Aurélia Poujois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 7.  Sleep Abnormalities in Wilson's Disease.

Authors:  Valérie Cochen De Cock; Nadège Girardot-Tinant; France Woimant; Aurélia Poujois
Journal:  Curr Treat Options Neurol       Date:  2018-09-27       Impact factor: 3.598

Review 8.  Advances in Treatment of Wilson Disease.

Authors:  Annu Aggarwal; Mohit Bhatt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2018-02-28

9.  Effects of High-Frequency Repetitive Transcranial Magnetic Stimulation on Upper Limb Dystonia in Patients With Wilson's Disease: A Randomized Controlled Trial.

Authors:  Wenjie Hao; Taohua Wei; Wenming Yang; Yue Yang; Ting Cheng; Xiang Li; Wei Dong; Hailin Jiang; Nannan Qian; Han Wang; Meixia Wang
Journal:  Front Neurol       Date:  2021-12-14       Impact factor: 4.003

10.  Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson's Disease: Six Cases and Literature Review.

Authors:  Harald Hefter; Sara Samadzadeh
Journal:  Toxins (Basel)       Date:  2021-03-29       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.